GW Henssler & Associates’s National Health Investors NHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-8,066
Closed -$423K – 250
2023
Q2
$423K Hold
8,066
– – 0.03% 112
2023
Q1
$416K Buy
8,066
+27
+0.3% +$1.47K 0.03% 121
2022
Q4
$420K Buy
8,039
+12
+0.1% +$658 0.03% 119
2022
Q3
$454K Sell
8,027
-473
-6% -$29.8K 0.03% 103
2022
Q2
$515K Sell
8,500
-10,599
-55% -$603K 0.04% 102
2022
Q1
$1.13M Buy
19,099
+166
+0.9% +$9.45K 0.07% 88
2021
Q4
$1.09M Buy
18,933
+1,733
+10% +$95.9K 0.07% 93
2021
Q3
$920K Hold
17,200
– – 0.06% 87
2021
Q2
$1.15M Buy
17,200
+487
+3% +$34K 0.08% 92
2021
Q1
$1.21M Buy
16,713
+100
+0.6% +$6.98K 0.09% 88
2020
Q4
$1.15M Sell
16,613
-599
-3% -$38.1K 0.09% 86
2020
Q3
$1.04M Buy
17,212
+500
+3% +$30.9K 0.09% 84
2020
Q2
$1.01M Buy
+16,712
New +$918K 0.09% 81

Other funds holding NHI

GW Henssler & Associates's NHI Position: Q3 2023 in Review

GW Henssler & Associates sold out of National Health Investors (NHI) in Q3 2023, closing a stake of 8,066 shares — an estimated $423K sold.

GW Henssler & Associates first reported a position in NHI in Q2 2020 and held it in 13 quarters. The position peaked at $1.21M in Q1 2021. 209 funds tracked by Wall St. Rank hold NHI as of Q3 2023.

  • GW Henssler & Associates reported no remaining National Health Investors position as of Q3 2023 after selling out during the quarter.
  • GW Henssler & Associates sold 8,066 National Health Investors shares in Q3 2023, an estimated $423K.
  • GW Henssler & Associates first reported a position in National Health Investors in Q2 2020 and held it in 13 quarters.
  • GW Henssler & Associates's National Health Investors position peaked at $1.21M in Q1 2021.
  • 209 funds tracked by Wall St. Rank held National Health Investors as of Q3 2023.

Based on GW Henssler & Associates's 13F filing for Q3 2023, filed 24 Oct 2023.